Congenital muscular dystrophy

Gene: HNRNPA2B1

Green List (high evidence)

HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1)
EnsemblGeneIds (GRCh38): ENSG00000122566
EnsemblGeneIds (GRCh37): ENSG00000122566
OMIM: 600124, Gene2Phenotype
HNRNPA2B1 is in 4 panels

3 reviews

Eleanor Williams (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to green following NHS Genomic Medicine Service approval.
Created: 1 Feb 2023, 4:51 p.m. | Last Modified: 1 Feb 2023, 4:51 p.m.
Panel Version: 3.22

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

Comment on list classification: There is enough evidence for this gene to be rated GREEN at the next major review.
Created: 15 Dec 2022, 12:02 p.m. | Last Modified: 15 Dec 2022, 12:02 p.m.
Panel Version: 3.11
Comment on phenotypes: The OMIM phenotype for HNRNPA2B1 (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, OMIM:615422) is based on one family. PMID: 35484142 presents further variants associated with an expanded phenotype.
Created: 15 Dec 2022, 12:01 p.m. | Last Modified: 15 Dec 2022, 12:01 p.m.
Panel Version: 3.10
PMID: 35484142 reports nine heterozygous terminating HNRNPA2B1 variants in ten unrelated cases of early onset severe, progressive muscular dystrophy, reminiscent of oculopharyngeal muscular dystrophy (OPMD)
Created: 15 Dec 2022, 11:57 a.m. | Last Modified: 15 Dec 2022, 11:57 a.m.
Panel Version: 3.9
The Q1_22_rating tag has been added as the GMS review for this gene has not been received to date
Created: 3 Feb 2022, 4:16 p.m. | Last Modified: 3 Feb 2022, 4:16 p.m.
Panel Version: 2.21
Comment on list classification: De novo terminating variants clustered in the C-terminus of the protein have been reported in six unrelated families all with a distinct class of dominantly-acting heterozygous variants in hnRNPA2B1 with a unique clinical phenotype of early childhood-onset progressive muscle weakness, ophthalmoplegia, ptosis, dysphagia, and variable degrees of respiratory insufficiency but no dementia (https://www.nmd-journal.com/article/S0960-8966(20)30203-0/fulltext).
This source is a meeting abstract an there is no peer reviewed source at this time.

There is enough evidence for this gene to be green, but GMS opinion is required to confirm this.
Created: 12 Jan 2021, 3:02 p.m. | Last Modified: 28 Jan 2021, 5:54 p.m.
Panel Version: 2.5

Phenotypes
early-onset oculopharyngeal muscular dystrophy

Publications

Anna Sarkozy (Great Ormond Street Hospital)

Green List (high evidence)

ten independent families reported with a severe, progressive muscular dystrophy with early onset, and de novo frameshift variants in this gene. phenotype is caractherised by symptoms onset before 2 years of age with severe respiratory insufficiency, delayed motor milestones, ptosis and ophthalmoplegia, axial weakness, progressive proximal and distal weakness. Creatine kinase levels were elevated. Disease-causing frameshift mutations abolish the native stop codon and extend the reading frame, creating novel transcripts that escape nonsense-mediated decay and alter the nucleocytoplasmic transport dynamics. in view of this evidence this gene should be upgraded to green
Created: 10 Nov 2022, 12:35 p.m. | Last Modified: 10 Nov 2022, 12:35 p.m.
Panel Version: 2.31
de novo variants in this gene have been reported in multiple unrelated families and presented at the World muscle society congress 2020, a full publication is currently in progress. see abstract:
https://www.nmd-journal.com/article/S0960-8966(20)30203-0/fulltext
Sources: Other, Expert list, Research
Created: 8 Dec 2020, 2:21 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
early-onset oculopharyngeal muscular dystrophy, muscular dystrophy, congenital myopathy

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • NHS GMS
  • Expert Review Green
Phenotypes
  • Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, OMIM:615422
OMIM
600124
Clinvar variants
Variants in HNRNPA2B1
Penetrance
None
Publications
Panels with this gene

History Filter Activity

3 Feb 2023, Gel status: 3

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: HNRNPA2B1 were changed from early-onset oculopharyngeal muscular dystrophy, muscular dystrophy, congenital myopathy to Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, OMIM:615422

3 Feb 2023, Gel status: 3

Removed Tag

Arina Puzriakova (Genomics England Curator)

Tag watchlist was removed from gene: HNRNPA2B1.

1 Feb 2023, Gel status: 3

Removed Tag, Removed Tag, Removed Tag

Eleanor Williams (Genomics England Curator)

Tag for-review was removed from gene: HNRNPA2B1. Tag Q1_22_rating was removed from gene: HNRNPA2B1. Tag Q4_22_promote_green was removed from gene: HNRNPA2B1.

1 Feb 2023, Gel status: 3

Added New Source, Added New Source, Status Update

Eleanor Williams (Genomics England Curator)

Source Expert Review Green was added to HNRNPA2B1. Source NHS GMS was added to HNRNPA2B1. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

15 Dec 2022, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag Q4_22_promote_green tag was added to gene: HNRNPA2B1.

15 Dec 2022, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: hnrnpa2b1 has been classified as Amber List (Moderate Evidence).

15 Dec 2022, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: HNRNPA2B1 were changed from ?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, OMIM:615422; inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, MONDO:0014178 to early-onset oculopharyngeal muscular dystrophy, muscular dystrophy, congenital myopathy

15 Dec 2022, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: HNRNPA2B1 were changed from oculopharyngodistal myopathy, muscular dystrophy, congenital myopathy to ?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, OMIM:615422; inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, MONDO:0014178

15 Dec 2022, Gel status: 2

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: HNRNPA2B1 were set to https://www.nmd-journal.com/article/S0960-8966(20)30203-0/fulltext

3 Feb 2022, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag Q1_22_rating tag was added to gene: HNRNPA2B1.

12 Jan 2021, Gel status: 2

Added Tag, Added Tag

Sarah Leigh (Genomics England Curator)

Tag watchlist tag was added to gene: HNRNPA2B1. Tag for-review tag was added to gene: HNRNPA2B1.

12 Jan 2021, Gel status: 2

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: HNRNPA2B1 were set to

12 Jan 2021, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: hnrnpa2b1 has been classified as Amber List (Moderate Evidence).

8 Dec 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Anna Sarkozy (Great Ormond Street Hospital)

gene: HNRNPA2B1 was added gene: HNRNPA2B1 was added to Congenital muscular dystrophy. Sources: Other,Expert list,Research Mode of inheritance for gene: HNRNPA2B1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: HNRNPA2B1 were set to oculopharyngodistal myopathy, muscular dystrophy, congenital myopathy Review for gene: HNRNPA2B1 was set to GREEN